Brain Area Linked to Auditory Verbal Hallucination in Schizophrenia

Schizophrenia is a serious mental disorder that affects a person's ability to think and behave precisely. A particular brain area which is involved in an auditory verbal hallucination in schizophrenia patients has been identified. Targeting the brain area with magnetic pulses can improve the condition in some patients, according to a new study presented at the ECNP conference in Paris.

"This is the first controlled trial to precisely determine an anatomically defined brain area where high frequency magnetic pulses can improve the hearing of voices", said lead researcher, Professor Sonia Dollfus (University of Caen, CHU, France).

Yogurt Helps Ease Psychiatric Symptoms in Schizophrenia Patients
Candida yeast contributes to bowel difficulties in men with schizophrenia but treatment with probiotics could treat general psychiatric symptoms and bowel function.

‘Schizophernia is a serious mental disorder that affects a person's ability to think, feel and behave clearly. Transcranial Magnetic Stimulation (TMS) is a new possible way of treating the hearing of voices in schizophrenia. ’

Tweet it Now

Schizophrenia is a serious long-term mental health problem. People with schizophrenia experience a range of symptoms, which may include delusions, muddled thoughts and hallucinations.

One of the best-known is hearing voices, also known as Auditory Verbal Hallucination (AVH), which around 70% of people with schizophrenia experience at some point. These voices, may be 'heard' as having a variety of different characteristics, for example as internal or external, friendly or threatening, they may be continuously present or present only occasionally, and so on.

Transcranial Magnetic Stimulation (TMS) has been suggested as a possible way of treating the hearing of voices in schizophrenia. TMS uses magnetic pulses to the brain, and has been shown to be effective in several psychiatric conditions. However, there is a lack of controlled trials to show that TMS works effectively with AVH sufferers.

RNA Splicing Associated With Schizophrenia Risk
DNA regions that show alterations in gene expression which lead to the development of schizophrenia have been identified; this promises early disease diagnosis.

The French research team worked with 26 patients who received active TMS treatment, and 33 as a control group, who received sham (placebo) treatment. The researchers interviewed the patients using a standard protocol - the Auditory Hallucinations Rating Scale - which revealed most of the characteristic features of the voices which they were hearing.

The treated patients received a series of 20 Hz high-frequency magnetic pulses over 2 sessions a day for 2 days. Using magnetic resonance imaging (MRI), the pulses were targeted at a specific brain area in the temporal lobe, which is associated with language (the exact area is the crossing of the projection of the ascending branch of the left lateral sulcus and the left superior temporal sulcus)

Insufficient Weight Gain During Pregnancy Associated With Schizophrenia In Children
Insufficient weight gain during pregnancy was associated with increased risk for nonaffective psychosis in children later in life.

After 2 weeks, the patients were re-evaluated. The researchers found that 34.6% of the patients being treated by TMS showed a significant response, whereas only 9.1% of patients in the sham group responded ('significant response' was defined as a more than 30% decrease in the Total Auditory Hallucinations Rating Scale score).

Professor Sonia Dollfus said: "Auditory Verbal Hallucinations, or "hearing voices" can be a disturbing symptom of schizophrenia, both for patients and for those close to sufferers. This is the first controlled trial to show an improvement in these patients by targeting a specific area of the brain and using high frequency TMS.

Brain Stimulation Boosts Cognitive Performance in People With Schizophrenia
Cognitive deficits were treated in people with schizophrenia with brain stimulation. The improvement was due to transcranial direct current stimulation (tDCS).

This means two things; firstly it seems that we now can say with some certainty that we have found a specific anatomical area of the brain associated with auditory verbal hallucinations in schizophrenia.

Secondly, we have shown that treatment with high frequency TMS makes a difference to at least some sufferers, although there is a long way to go before we will know if TMS is the best route to treat these patients in the long-term".

Commenting, Professor Andreas Meyer-Lindenberg, Central Institute of Mental Health, Mannheim and member of the ECNP executive board, said: "This work builds on previous studies that have shown a critical role of excessive activity of subregions of the temporal lobe in the generation of voice hallucinations in schizophrenia.

To move this into treatment, controlled trial such as the one by Dollfus and coworkers are important. While response rates were moderate, TMS is a welcome addition to the therapeutic repertoire especially for patients who do not respond to medication."

This work has been accepted in the peer-reviewed journal Schizophrenia Bulletin: The Journal of Psychoses and Related Disorders.

Source-Eurekalert